The annual number of drug overdose deaths in the United States involving opioids has more than quadrupled since 1999, a new report from the Congressional Research Service notes.
“CDC estimates that in 2016, more than 63,000 people died from a drug overdose, and more than 42,000 of these deaths involved prescription or illicit opioids.” See The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action, June 5, 2018.
Other new and updated reports from the Congressional Research Service include the following.
Increase in Illicit Fentanyl Overdose Deaths, CRS Insight, June 6, 2018
Capital Markets, Securities Offerings, and Related Policy Issues, June 8, 2018
The Rise and Decline of the Alien Tort Statute, CRS Legal Sidebar, June 6, 2018
Intelligence Planning, Programming, Budgeting and Evaluation Process (IPPBE), CRS In Focus, May 30, 2018
Recent Trends in Active-Duty Military Deaths, CRS In Focus, June 1, 2018
Expedited Citizenship through Military Service, CRS In Focus, May 11, 2018
Egypt: Background and U.S. Relations, updated June 7, 2018
Department of State, Foreign Operations and Related Programs: FY2019 Budget and Appropriations, updated June 8, 2018
How to Develop and Write a Grant Proposal, updated June 7, 2018
If you’re new to the climate intervention space, welcome! The TL;DR: if we can’t stop the most catastrophic impacts of climate change with current tools quickly enough, then we need a bigger toolbox.
After months of delay, the council tasked by President Trump to review the FEMA released its final report. Our disaster policy nerds have thoughts.
FAS and FLI partnered to build a series of convenings and reports across the intersections of artificial intelligence (AI) with biosecurity, cybersecurity, nuclear command and control, military integration, and frontier AI governance. This project brought together leaders across these areas and created a space that was rigorous, transpartisan, and solutions-oriented to approach how we should think about how AI is rapidly changing global risks.
Investment should instead be directed at sectors where American technology and innovation exist but the infrastructure to commercialize them domestically does not—and where the national security case is clear.